VANDORTUZUMAB
UNII O5EGV7ISVU

Substance Identification & Data

This profile provides standardized clinical and technical data for Vandortuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) O5EGV7ISVU.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1557989-52-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

O5EGV7ISVU

CAS Registry Number

1557989-52-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VANDORTUZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C152826

National Cancer Institute reference terminology for clinical and research data.

USAN ID

DE-27

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vandortuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VANDORTUZUMAB

Common Names & Synonyms

VANDORTUZUMAB [USAN]

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN ANTIGEN STEAP1 (SIX TRANSMEMBRANE EPITHELIAL ANTIGEN OF PROSTATE 1)) (HUMAN-MUS MUSCULUS MONOCLONAL MSTP2109A HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MSTP2109A .KAPPA.-CHAIN, DIMER

SYS